विवरण
About the Webinar:
Uterine fibroids are benign tumors that grow in the wall of the uterus. They can cause a variety of symptoms, including heavy bleeding, pain, and infertility. Management of uterine fibroids can involve a range of treatment options, depending on the severity of the condition. The first step in managing uterine fibroids is to identify the type, size, and location of the fibroids. This can be done through imaging tests such as an ultrasound or MRI. Once the type, size, and location of the fibroids are determined, the most appropriate treatment option can be chosen. Some fibroids do not require treatment, especially if they are small and do not cause any symptoms. However, if fibroids are causing symptoms or affecting fertility, treatment may be necessary. The management of uterine fibroids can be divided into two categories: medical and surgical. Medical management involves the use of medication to control symptoms or shrink the fibroids.
सारांश
- Uterine fibroids are benign tumors affecting women in their reproductive years, with higher incidence in African-American women. Risk factors include early menarche, nulliparity, family history, obesity, high blood pressure, and excessive intake of caffeine, red meat, alcohol, and sugar. Fibroids have estrogen and progesterone receptors, making them hormone-dependent and prone to growth during pregnancy.
- Most women with fibroids are asymptomatic, but common symptoms include heavy menstrual bleeding, pelvic pain, and infertility. Fibroid location is crucial, categorized as sub-mucosal (inside the uterine cavity), intramural (within the myometrium), and sub-serosal (outside). Diagnosis involves physical examination, pelvic examination, and imaging modalities like transvaginal ultrasound and MRI.
- Treatment selection considers patient age, desire for fertility, and symptom severity. Options include expectant management, medical management (non-hormonal and hormonal), surgical management (myomectomy and hysterectomy), and minimally invasive procedures.
- Medical options include non-hormonal (NSAIDs, tranexamic acid) and hormonal therapies (oral contraceptives, progestins, levonorgestrel intrauterine devices, GnRH analogs, and selective progesterone receptor modulators). Levonorgestrel IUDs like Mirena offer local hormone release with systemic effects, suitable for women in their thirties and those with contraindications to other hormonal treatments.
- Surgical management includes myomectomy (fibroid removal to preserve fertility) and hysterectomy (definitive treatment). Open, laparoscopic, robotic, and hysteroscopic approaches exist, depending on fibroid size, location, and patient history. Non-invasive procedures such as uterine artery embolization and MRI-guided focused ultrasound are options for women avoiding or unfit for surgery, though future fertility concerns exist with embolization.
- Emerging therapies like gene and targeted drug therapy are under research. Management requires considering symptoms, age, fertility desire, and fibroid location, along with counseling patients on medical and surgical complications and recurrence.
नमूना प्रमाण पत्र
वक्ताओं के बारे में
Dr Maitrayee Chennu
Consultant Obstetrician and Gynaecologist Sankhya Hospitals, Hyderabad
टिप्पणियाँ
टिप्पणियाँ
टिप्पणी करने के लिए आपको लॉगिन होना होगा।